EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting PI3K/AKT/mTOR Pathway Exerts Inhibitory Effects on Endothelial Cells from Generalized Lymphatic Anomaly

Bruno Lorusso iD, Laura Finato iD, Antonella Nogara iD, Giovanni Roti, Anna Montanaro iD, Gregorio Monica iD, Alice Andreani, Gallia Graiani iD, Pellegrino Crafa iD, Enrico Maria Silini iD, Letizia Gnetti, Francesco Paolo Pilato iD und 5 weitere

Cells · 2026

DOI: 10.3390/cells15201860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Bruno Lorusso und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Endothelial Cells, Proto-Oncogene Proteins c-akt, Signal Transduction. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Parma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Generalized lymphatic anomaly (GLA) is a congenital, non-neoplastic vascular anomaly characterized by diffuse or multifocal involvement and infiltration of multiple organs. Most GLA cases harbor “hotspot” somatic missense single nucleotide mutations in the PIK3CA gene, whereas a minority involve mutations in other genes. Recently, rapamycin and its homologs have shown encouraging results in the treatment of alterations affecting the PI3K/AKT/mTOR pathway. Therefore, the present work aimed to expand the immunophenotypic characterization of the lymphatic lesion at the tissue level and to evaluate the in vitro viability, migration, and angiogenic capacity of endothelial cells freshly isolated from a PIK3CA-mutated GLA sample, following treatment with alpelisib, rapamycin, dactolisib, and buparlisib. We detected the p.Gln546Lys amino acid substitution in the PI3Kca helical domain in GLA-derived endothelial cells. Then, by immunohistochemical analysis, we documented altered expression of mTOR and its well-characterized downstream substrates, which regulate growth, proliferation, migration, angiogenesis, and survival of ECs. Finally, pharmacological treatment reduced GLA-EC functional properties and down-modulated the hyperactivated PI3K downstream substrates. Overall, our results suggest that routine immunohistochemistry, integrated with phospho-protein analysis and next-generation sequencing, might improve histopathological classification of vascular anomalies and facilitate the development of personalized targeted therapies, particularly in recurrent or surgically challenging cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesEndothelial CellsProto-Oncogene Proteins c-aktSignal TransductionLymphatic AbnormalitiesPhosphatidylinositol 3-KinasesHumansCell MovementClass I Phosphatidylinositol 3-KinasesCell ProliferationMaleAngiogenesis

Stichwörter der Autor:innen

PI3Kca mutationalpelisibangiogenesisbuparlisibdactolisibgeneralized lymphatic anomalyimmunohistochemistrylymphatic endothelial cellsmigrationrapamycin

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesClass I Phosphatidylinositol 3-KinasesPIK3CA protein, humanMTOR protein, human

Autor:innen und Institutionen

  • Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
  • Translational Hematology and Chemogenomics (THEC), University of Parma, 43126 Parma, Italy.
  • Hematology and BMT Unit, University Hospital of Parma, 43126 Parma, Italy.
  • Dental School, University of Parma Medical School, 43126 Parma, Italy.
  • Pathology Unit, University Hospital of Parma, 43126 Parma, Italy.
  • Pediatric Surgery, Ospedale dei Bambini of Parma, University Hospital of Parma, 43126 Parma, Italy.

ORCID-Profile: Bruno Lorusso, Laura Finato, Antonella Nogara, Anna Montanaro, Gregorio Monica, Gallia Graiani, Pellegrino Crafa, Enrico Maria Silini, Francesco Paolo Pilato, Federico Quaini, Costanza Anna Maria Lagrasta

Förderung

  • University of Parma

Zitieren

APA

Lorusso, B., Finato, L., Nogara, A., Roti, G., Montanaro, A., Monica, G., Andreani, A., Graiani, G., Crafa, P., Silini, E. M., Gnetti, L., Pilato, F. P., Bottarelli, L., Azzoni, C., Cerasoli, G., Quaini, F., & Lagrasta, C. A. M. (2026). Targeting PI3K/AKT/mTOR Pathway Exerts Inhibitory Effects on Endothelial Cells from Generalized Lymphatic Anomaly. Cells. https://doi.org/10.3390/cells15201860

Vancouver

Lorusso B, Finato L, Nogara A, Roti G, Montanaro A, Monica G, et al. Targeting PI3K/AKT/mTOR Pathway Exerts Inhibitory Effects on Endothelial Cells from Generalized Lymphatic Anomaly. Cells. 2026. doi:10.3390/cells15201860

BibTeX
@article{Lorusso2026,
  author = {Lorusso, Bruno and Finato, Laura and Nogara, Antonella and Roti, Giovanni and Montanaro, Anna and Monica, Gregorio and Andreani, Alice and Graiani, Gallia and Crafa, Pellegrino and Silini, Enrico Maria and Gnetti, Letizia and Pilato, Francesco Paolo and Bottarelli, Lorena and Azzoni, Cinzia and Cerasoli, Giuseppe and Quaini, Federico and Lagrasta, Costanza Anna Maria},
  title = {Targeting PI3K/AKT/mTOR Pathway Exerts Inhibitory Effects on Endothelial Cells from Generalized Lymphatic Anomaly},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15201860}
}
Kostenlos starten →